Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Blood Loss: full-pipeline trial registry
2 of 10 indexed Blood Loss trials are currently recruiting.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · 2 currently recruiting · #1,724 of 28,707 conditions by registered trial count
Blood Loss: 10 US clinical trials tracked, 2 recruiting.
Blood Loss is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Zynex Monitoring Solutions, running 1 of these trials.
Enrollment posture brief
Registry condition blood-loss
OPEN 2 | RECR 20% | LATE 3 | EARLY 4 | RANK #1724 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acral Lentiginous Melanoma (20% recruiting · 5 trials)
Blood Loss lists 2 open slots (20% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Blood Loss on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Blood Loss is recruiting below its size-band peers.
2 of 10 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Blood Loss trials is spread across many organizations.
Zynex Monitoring Solutions accounts for 1 of 10 trials (10%). 10 distinct sponsors appear on at least one study for this condition label.
-
Typical Blood Loss enrolment sits around 200 participants.
Median target enrolment is 200 among the 10 trials that report a genuine target (sentinel values excluded). 3 of those (30%) plan for fewer than 100 participants.
-
Blood Loss research is mostly interventional.
10 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
10 total, page 1 of 1
Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes
University of California, San Diego
NCT06820177
Oxytocin Pharmacokinetics and Pharmacodynamics
University of Chicago
NCT05488457
Extended Postoperative Oral Tranexamic Acid in Knee Replacement
Campbell Clinic
NCT05099276
LBNP Tolerance With Skin Warming After Exercise Cold Stress
University of Colorado, Colorado Springs
NCT06279897
Oral Versus Intravenous Tranexamic Acid
Hospital for Special Surgery, New York
NCT04089865
Frozen Red Blood Cell Transfusions in Trauma Patients
Oregon Health and Science University
NCT01038557
Outcomes and Safety Trial Investigating Ecallantide's Effect on Reducing Surgical Blood Loss Volume in Subjects at High Risk of Bleeding Exposed to Cardio-pulmonary Bypass During Cardiac Surgery
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
NCT00888940
Clinical Evaluation of the CM-1500 in Postoperative Surgery Patients
Zynex Monitoring Solutions
NCT04706221
Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery
University of Texas Southwestern Medical Center
NCT03856164
Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes for Dilation and Evacuation
University of Hawaii
NCT04651166
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 4 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Blood Loss records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Blood Loss trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Blood Loss page
10 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Blood Loss trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Zynex Monitoring Solutions sponsors the most Blood Loss trials on record, review their full trial history before evaluating a specific study. See Zynex Monitoring Solutions's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Blood Loss condition card totals 10 registered trials; most-linked intervention Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.